|
Volumn 325, Issue 7375, 2002, Pages 1287-1289
|
ABC of antithrombotic therapy: Antithrombotic therapy in myocardial infarction and stable angina
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
ALTEPLASE;
ANISTREPLASE;
ANTIANGINA PECTORIS AGENT;
ANTICOAGULANT AGENT;
ANTITHROMBOCYTIC AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
DALTEPARIN;
DIPYRIDAMOLE;
FIBRINOLYTIC AGENT;
HEPARIN;
NITRATE;
RETEPLASE;
STREPTOKINASE;
TENECTEPLASE;
TICLOPIDINE;
ANTICOAGULANT THERAPY;
ARTIFICIAL EMBOLISM;
BLEEDING TENDENCY;
BLOOD CLOT LYSIS;
CARDIOVASCULAR RISK;
CLINICAL FEATURE;
CLINICAL TRIAL;
DISEASE COURSE;
DOSE RESPONSE;
DRUG CHOICE;
DRUG HALF LIFE;
ELECTROCARDIOGRAM;
FIBRINOLYTIC THERAPY;
HEART INFARCTION;
HUMAN;
LONG TERM CARE;
PARTIAL THROMBOPLASTIN TIME;
PRIORITY JOURNAL;
RISK ASSESSMENT;
SHORT SURVEY;
ST SEGMENT ELEVATION;
STABLE ANGINA PECTORIS;
THROMBOEMBOLISM;
TREATMENT CONTRAINDICATION;
TREATMENT INDICATION;
TREATMENT OUTCOME;
VEIN THROMBOSIS;
|
EID: 0037202689
PISSN: 09598146
EISSN: None
Source Type: Journal
DOI: 10.1136/bmj.325.7375.1287 Document Type: Short Survey |
Times cited : (9)
|
References (0)
|